Skip to content
Single Family OfficePuts its own capital into companiesLAST VERIFIED Oct 2026 · 5 SOURCES

Nolsterby Invest

Also known as Nolsterby Invest AB

Stockholm-Uppsala family office founded 2017, majority-owned by medtech entrepreneur Erik Hedlund; evergreen investor in listed and unlisted healthcare, mainly growth-stage medtech.

USEFUL FOR Business owners seeking a long-term partner · Co-investors

Family & background

HEADQUARTERS
Uppsala, Sweden
FOUNDED
2017
OUTSIDE CAPITAL
No — own capital only

Investment approach

SECTORS
HealthTechBiotech & Life Sciences
STAGES
Growth
ROUTES
Companies (own capital)
STRATEGIES
Direct investmentsVenture capitalPublic equities

Overview

Nolsterby Invest AB is a Stockholm-Uppsala family office founded in 2017 and fully operational since 2021, when Anders Hedlund joined as CEO; it is majority-owned by Erik Hedlund, a serial entrepreneur in medical technology. It invests in listed and unlisted healthcare companies across medtech, diagnostics, biotech, life-science tools and healthtech, with its core in growth-stage medtech, always co-syndicating with trusted investors. Holdings shown include Occlutech, Leo Cancer Care, Perpetua Medical (which it re-founded), Akiram Therapeutics and Peptisystems.

Investment thesis

Evergreen investor in healthcare without an explicit exit strategy; core investments in growth-stage medtech companies with clear clinical applications, smaller tickets in diagnostics, biotech, life-science tools and healthtech; invests in people and always co-syndicates with trusted investors.

Holdings & investments (9)

  • Leo Cancer Care
    HealthTech · since 2026 · unlisted
  • Perpetua Medical
    HealthTech · since 2024 · listed; re-founder and active owner
  • TIRmed Pharma
    Biotech & Life Sciences · since 2024 · unlisted
  • Collective Minds Radiology
    HealthTech · since 2024 · unlisted
  • Dvysr
    Biotech & Life Sciences · since 2023 · listed
  • Peptisystems
    Biotech & Life Sciences · since 2023 · unlisted
  • Akiram Therapeutics
    Biotech & Life Sciences · since 2022 · unlisted
  • Younium
    Software & SaaS · since 2022 · unlisted
  • Occlutech
    HealthTech · since 2021 · unlisted

People

  • Erik Hedlund
    Majority owner · source
  • Anders Hedlund
    CEO and Co-Founder · source
  • Erik Lantz
    Analyst · source

Frequently asked questions

Nolsterby Invest is a single family office based in Uppsala, Sweden, founded in 2017.

Nolsterby Invest invests its own capital into companies. Its stated asset mix includes direct investments, venture capital and public equities.

Nolsterby Invest invests at Growth stage in HealthTech and Biotech & Life Sciences.

Key people at Nolsterby Invest include Erik Hedlund (Majority owner), Anders Hedlund (CEO and Co-Founder) and Erik Lantz (Analyst).

Nolsterby Invest's holdings and investments include Leo Cancer Care, Occlutech, Perpetua Medical, Dvysr, Akiram Therapeutics, TIRmed Pharma, Peptisystems and Collective Minds Radiology, among others.

No. Nolsterby Invest invests its own capital and does not raise money from outside investors.